COYA
Coya Therapeutics, Inc.
+0.41 (+9.19%)4.87USD135K成交股數114M市值–本益比(近四季)14.3股價營收比+49.0%營收年增(近四季)2026-11-11下次財報
財報 SEC XBRL 申報值 · 美元 · 財年於 12 月結束
逐季數字是 10-Q 的單季值;財年第四季 XBRL 只有年度值,這裡用年度減前三季推算。年增率比的是去年同一會計季。
營收與利潤率近 16 季
稀釋 EPS近 16 季 · 美元
現金流近 16 季
股東回饋近 16 季 · 庫藏股與股利
損益表 逐季 · 最新在左 · 小字是年增率
| 科目 | 26Q2 | 26Q1 | 25Q3 | 25Q2 | 25Q1 | 24Q4 | 24Q3 | 24Q2 | 24Q1 | 23Q3 | 23Q2 | 23Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 營收 | 244K-5% | 251K+12766% | 3.6M | 164K-95% | 258K+103% | 2K | 0.00 | 3.4M | 127K | 0.00 | 0.00 | 0.00 |
| 營業成本 | – | – | – | – | – | – | – | – | – | – | – | – |
| 毛利 | – | – | – | – | – | – | – | – | – | – | – | – |
| 毛利率 | – | – | – | – | – | – | – | – | – | – | – | – |
| 研發費用 | 5.0M | 4.1M | 2.9M | 3.7M | 5.2M | 1.9M | 2.2M | 4.6M | 3.1M | 1.6M | 1.1M | 1.2M |
| 銷售管理費用 | 2.3M | 3.8M | 2.6M | 2.9M | 2.7M | 2.1M | 2.2M | 2.1M | 2.4M | 2.0M | 1.8M | 1.7M |
| 營業利益 | −7.0M-8% | −7.6M+87% | −2.4M-45% | −6.4M+98% | −7.7M+40% | −4.1M+14% | −4.5M+37% | −3.2M+12% | −5.5M | −3.6M | −3.3M | −2.9M |
| 營業利益率 | -2,891.1% | -3,042.1% | -68.3% | -3,920.5% | -2,976.9% | -209,031.5% | – | -94.5% | -4,322.8% | – | – | – |
| 稅後淨利 | −6.6M-9% | −7.2M+147% | −2.1M-47% | −6.1M+111% | −7.3M+45% | −2.9M-15% | −4.0M+30% | −2.9M+6% | −5.1M | −3.4M | −3.1M | −2.7M |
| 淨利率 | -2,723.4% | -2,869.6% | -59.4% | -3,725.2% | -2,833.4% | -149,373.8% | – | -84.4% | -3,983.0% | – | – | – |
| 稀釋 EPS | -0.28-36% | -0.32+78% | -0.13-50% | -0.36+89% | -0.44+26% | -0.18-47% | -0.26-16% | -0.19-32% | -0.35 | -0.34 | -0.31 | -0.28 |
| 稀釋股數 | 23.5M | 22.6M | 16.7M | 16.7M | 16.7M | 15.2M | 15.2M | 14.9M | 14.5M | 9.9M | 9.9M | 9.7M |
資產負債表 期末餘額
| 科目 | 26Q2 | 26Q1 | 25Q3 | 25Q2 | 25Q1 | 24Q4 | 24Q3 | 24Q2 | 24Q1 | 23Q3 | 23Q2 | 23Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 現金與約當現金 | 43.2M | 50.7M | 28.1M | 29.8M | 35.5M | 38.3M | 31.1M | 36.6M | 36.0M | 10.9M | 13.1M | 16.3M |
| 應收帳款 | – | – | – | – | – | – | – | – | – | – | – | – |
| 存貨 | – | – | – | – | – | – | – | – | – | – | – | – |
| 總資產 | 47.3M | 53.3M | 32.0M | 33.5M | 38.4M | 44.3M | 35.6M | 39.9M | 37.4M | 11.9M | 14.5M | 17.4M |
| 有息負債 | – | – | – | – | – | – | – | – | – | – | – | – |
| 總負債 | 4.0M | 4.3M | 4.8M | 5.1M | 5.0M | 4.8M | 3.5M | 4.7M | 5.0M | 1.8M | 1.2M | 1.3M |
| 股東權益 | 43.3M | 49.0M | 27.3M | 28.3M | 33.4M | 39.6M | 32.0M | 35.3M | 32.4M | 10.1M | 13.2M | 16.2M |
| 負債比 | 8.5% | 8.1% | 14.9% | 15.4% | 13.1% | 10.8% | 10.0% | 11.7% | 13.4% | 15.2% | 8.4% | 7.3% |
| 淨現金(現金 − 有息負債) | – | – | – | – | – | – | – | – | – | – | – | – |
現金流量表 單季
| 科目 | 26Q2 | 26Q1 | 25Q3 | 25Q2 | 25Q1 | 24Q4 | 24Q3 | 24Q2 | 24Q1 | 23Q3 | 23Q2 | 23Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 營業現金流 | – | −6.2M | – | – | −2.8M-232% | – | – | – | 2.1M | – | – | −3.9M |
| 資本支出 | – | – | – | – | – | – | – | – | – | – | – | – |
| 自由現金流 | – | – | – | – | – | – | – | – | – | – | – | – |
| 折舊攤銷 | – | – | – | – | – | – | – | – | – | – | – | – |
| 買回庫藏股 | – | – | – | – | – | – | – | – | – | – | – | – |
| 現金股利 | – | – | – | – | – | – | – | – | – | – | – | – |
| 自由現金流率 | – | – | – | – | – | – | – | – | – | – | – | – |
營收拆解
這家公司的 XBRL 沒有標分部、產品或地區營收。多半是單一業務,或只在 10-K 文字裡揭露。
各維度的加總不一定等於合併營收:分部有時含內部交易、地區有時只揭露主要國家。挑的是加總最接近合併營收的那個標籤。
年度 10-K
| 財年 | 營收 | 年增 | 稅後淨利 | 淨利率 | 稀釋 EPS | 自由現金流 |
|---|---|---|---|---|---|---|
| FY2025 | 7.9M | +123.6% | −21.2M | -267.1% | -1.27 | – |
| FY2024 | 3.6M | -40.8% | −14.9M | -418.7% | -0.98 | – |
| FY2023 | 6.0M | – | −8.0M | -133.1% | -0.79 | – |
| FY2022 | 0.00 | – | −12.2M | –% | -4.73 | – |
| FY2021 | – | – | −4.9M | –% | -1.89 | – |